Share Price and Basic Stock Data
Last Updated: January 14, 2026, 2:54 pm
| PEG Ratio | 8.30 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Carysil Ltd operates in the ceramics, tiles, and sanitaryware industry, showcasing a robust performance with a current market capitalization of ₹2,501 Cr and a share price of ₹879. The company’s revenue trajectory demonstrates a consistent upward trend, with sales reported at ₹594 Cr for the fiscal year ending March 2023, a significant increase from ₹484 Cr in the previous fiscal year. The latest quarterly results indicate continued growth, with revenue reaching ₹164 Cr in September 2023, and projected TTM sales standing at ₹875 Cr. This growth reflects Carysil’s ability to capture market demand effectively, particularly in a sector characterized by rising consumer interest in home improvement and renovation. The company has also reported steady sales growth on a quarterly basis, culminating in a forecasted sales figure of ₹816 Cr for FY 2025, indicating a compound annual growth rate that aligns with industry expectations. Overall, Carysil’s performance is indicative of a well-positioned player in a competitive market.
Profitability and Efficiency Metrics
Carysil’s profitability metrics illustrate a solid operational foundation, with a reported operating profit margin (OPM) of 19% and a net profit of ₹82 Cr for the year ending March 2025. The company’s operating profit for the same year is recorded at ₹140 Cr, reflecting an operational efficiency that is commendable within the sector. Notably, the net profit margin stood at 7.88%, slightly lower than previous periods, indicating a need for attention to cost management and pricing strategies. The interest coverage ratio (ICR) at 6.29x suggests that Carysil is well-equipped to service its debt obligations, a reassuring factor for investors. Furthermore, the return on equity (ROE) at 14.5% and return on capital employed (ROCE) at 15.4% highlight the firm’s effective utilization of capital in generating profits. While the company’s profitability is strong, maintaining these margins in a fluctuating market will require continuous operational excellence.
Balance Sheet Strength and Financial Ratios
Carysil’s balance sheet reflects a strategic approach to financial management, with total borrowings reported at ₹235 Cr and reserves growing to ₹560 Cr by September 2025. The company’s total assets stand at ₹1,046 Cr, indicating a healthy asset base to support ongoing operations and growth initiatives. The current ratio of 1.51x suggests adequate liquidity to meet short-term obligations, while a total debt-to-equity ratio of 0.50x reveals a conservative leverage strategy. Moreover, the book value per share has increased to ₹185.39, enhancing shareholder value. The enterprise value (EV) of ₹1,976.83 Cr, coupled with an EV to EBITDA ratio of 13.43x, indicates that Carysil is valued fairly in relation to its earnings. These financial ratios underscore the company’s stability and capacity to navigate potential economic headwinds while pursuing growth opportunities within the ceramics sector.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Carysil Ltd reveals a diverse ownership structure that offers insights into investor confidence. Promoters hold a significant 41.34% stake, reflecting a strong commitment to the company’s long-term vision. Institutional investors, including domestic institutional investors (DIIs) with an 11.33% stake and foreign institutional investors (FIIs) at 1.44%, indicate a growing institutional interest. However, the declining trend in promoter shareholding from 43.91% in December 2022 to the current 41.34% could raise questions among retail investors regarding future governance. The number of shareholders has decreased to 54,797, which may signal a consolidation phase or shifts in investor sentiment. Nonetheless, the company’s ability to attract institutional investors suggests a level of confidence in its operational and financial prospects. Overall, the shareholding dynamics reflect a mixed sentiment that could influence future capital-raising efforts.
Outlook, Risks, and Final Insight
Carysil Ltd is positioned for continued growth in the ceramics and sanitaryware market, driven by increasing consumer demand and an expanding product portfolio. However, the company faces risks associated with fluctuating raw material prices and potential supply chain disruptions, which could impact profitability. The current cash conversion cycle of 251 days indicates that Carysil may need to improve inventory management and receivables collection to enhance liquidity. Furthermore, a reliance on domestic markets could expose the company to regional economic fluctuations. Strengths such as a solid balance sheet, a diverse product range, and operational efficiencies provide a strong foundation for future growth. In navigating these challenges, Carysil has the potential to strengthen its market position significantly, provided it remains agile and responsive to market changes. Overall, the company’s strategic initiatives and market positioning will be critical in determining its success in the coming years.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Exxaro Tiles Ltd | 341 Cr. | 7.62 | 11.0/5.22 | 64.1 | 6.21 | 0.00 % | 3.49 % | 0.26 % | 1.00 |
| Carysil Ltd | 2,215 Cr. | 779 | 1,072/482 | 27.3 | 199 | 0.30 % | 15.4 % | 14.5 % | 2.00 |
| Somany Ceramics Ltd | 1,637 Cr. | 398 | 624/392 | 28.7 | 191 | 0.75 % | 11.5 % | 8.17 % | 2.00 |
| Orient Bell Ltd | 398 Cr. | 270 | 350/215 | 60.9 | 217 | 0.18 % | 2.38 % | 0.90 % | 10.0 |
| Nitco Ltd | 2,036 Cr. | 89.2 | 164/76.5 | 13.2 | 0.00 % | 42.9 % | % | 10.0 | |
| Industry Average | 3,439.78 Cr | 776.92 | 39.51 | 200.53 | 0.49% | 12.44% | 14.63% | 6.10 |
Quarterly Result
| Metric | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 139 | 138 | 146 | 142 | 164 | 188 | 191 | 201 | 207 | 203 | 204 | 227 | 241 |
| Expenses | 117 | 113 | 119 | 116 | 131 | 153 | 156 | 165 | 170 | 174 | 169 | 183 | 195 |
| Operating Profit | 22 | 25 | 26 | 26 | 33 | 35 | 35 | 36 | 37 | 29 | 35 | 44 | 46 |
| OPM % | 16% | 18% | 18% | 18% | 20% | 19% | 18% | 18% | 18% | 14% | 17% | 19% | 19% |
| Other Income | 0 | 0 | 1 | 1 | 1 | 1 | 2 | 1 | 2 | 4 | 2 | 1 | 5 |
| Interest | 4 | 4 | 4 | 5 | 5 | 6 | 6 | 6 | 6 | 6 | 5 | 5 | 5 |
| Depreciation | 6 | 7 | 7 | 7 | 8 | 8 | 9 | 9 | 10 | 9 | 8 | 9 | 10 |
| Profit before tax | 13 | 14 | 16 | 16 | 22 | 22 | 21 | 23 | 24 | 18 | 24 | 30 | 36 |
| Tax % | 26% | 15% | 23% | 25% | 28% | 31% | 26% | 30% | 27% | 31% | 20% | 24% | 25% |
| Net Profit | 9 | 12 | 12 | 12 | 16 | 15 | 16 | 16 | 17 | 13 | 19 | 23 | 27 |
| EPS in Rs | 3.46 | 4.50 | 4.64 | 4.32 | 5.76 | 5.72 | 5.79 | 5.91 | 5.91 | 4.40 | 6.54 | 8.02 | 9.56 |
Last Updated: December 27, 2025, 3:36 pm
Below is a detailed analysis of the quarterly data for Carysil Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Sales, as of Sep 2025, the value is 241.00 Cr.. The value appears strong and on an upward trend. It has increased from 227.00 Cr. (Jun 2025) to 241.00 Cr., marking an increase of 14.00 Cr..
- For Expenses, as of Sep 2025, the value is 195.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 183.00 Cr. (Jun 2025) to 195.00 Cr., marking an increase of 12.00 Cr..
- For Operating Profit, as of Sep 2025, the value is 46.00 Cr.. The value appears strong and on an upward trend. It has increased from 44.00 Cr. (Jun 2025) to 46.00 Cr., marking an increase of 2.00 Cr..
- For OPM %, as of Sep 2025, the value is 19.00%. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 19.00%.
- For Other Income, as of Sep 2025, the value is 5.00 Cr.. The value appears strong and on an upward trend. It has increased from 1.00 Cr. (Jun 2025) to 5.00 Cr., marking an increase of 4.00 Cr..
- For Interest, as of Sep 2025, the value is 5.00 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 5.00 Cr..
- For Depreciation, as of Sep 2025, the value is 10.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 9.00 Cr. (Jun 2025) to 10.00 Cr., marking an increase of 1.00 Cr..
- For Profit before tax, as of Sep 2025, the value is 36.00 Cr.. The value appears strong and on an upward trend. It has increased from 30.00 Cr. (Jun 2025) to 36.00 Cr., marking an increase of 6.00 Cr..
- For Tax %, as of Sep 2025, the value is 25.00%. The value appears to be increasing, which may not be favorable. It has increased from 24.00% (Jun 2025) to 25.00%, marking an increase of 1.00%.
- For Net Profit, as of Sep 2025, the value is 27.00 Cr.. The value appears strong and on an upward trend. It has increased from 23.00 Cr. (Jun 2025) to 27.00 Cr., marking an increase of 4.00 Cr..
- For EPS in Rs, as of Sep 2025, the value is 9.56. The value appears strong and on an upward trend. It has increased from 8.02 (Jun 2025) to 9.56, marking an increase of 1.54.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 4:00 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 106 | 127 | 174 | 181 | 196 | 252 | 276 | 310 | 484 | 594 | 684 | 816 | 875 |
| Expenses | 87 | 103 | 143 | 154 | 169 | 209 | 229 | 243 | 379 | 484 | 553 | 675 | 721 |
| Operating Profit | 19 | 24 | 31 | 27 | 27 | 42 | 48 | 67 | 105 | 110 | 131 | 140 | 154 |
| OPM % | 18% | 19% | 18% | 15% | 14% | 17% | 17% | 22% | 22% | 18% | 19% | 17% | 18% |
| Other Income | 1 | 1 | 2 | 3 | 5 | 2 | 5 | 8 | 10 | 2 | 5 | 9 | 12 |
| Interest | 5 | 8 | 9 | 11 | 8 | 12 | 10 | 8 | 11 | 17 | 23 | 26 | 21 |
| Depreciation | 5 | 4 | 5 | 6 | 7 | 9 | 12 | 13 | 18 | 26 | 32 | 36 | 36 |
| Profit before tax | 10 | 13 | 18 | 13 | 17 | 24 | 30 | 54 | 86 | 68 | 81 | 88 | 108 |
| Tax % | 25% | 32% | 32% | 37% | 28% | 28% | 25% | 27% | 24% | 22% | 28% | 27% | |
| Net Profit | 8 | 9 | 12 | 8 | 12 | 17 | 23 | 39 | 65 | 53 | 58 | 64 | 82 |
| EPS in Rs | 3.43 | 3.75 | 4.21 | 2.80 | 4.61 | 6.65 | 8.27 | 14.65 | 24.26 | 19.58 | 21.59 | 22.43 | 28.52 |
| Dividend Payout % | 23% | 21% | 24% | 36% | 22% | 18% | 15% | 14% | 10% | 10% | 9% | 11% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 12.50% | 33.33% | -33.33% | 50.00% | 41.67% | 35.29% | 69.57% | 66.67% | -18.46% | 9.43% | 10.34% |
| Change in YoY Net Profit Growth (%) | 0.00% | 20.83% | -66.67% | 83.33% | -8.33% | -6.37% | 34.27% | -2.90% | -85.13% | 27.90% | 0.91% |
Carysil Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 20% |
| 5 Years: | 24% |
| 3 Years: | 19% |
| TTM: | 13% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 22% |
| 5 Years: | 24% |
| 3 Years: | 0% |
| TTM: | 14% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 21% |
| 5 Years: | 51% |
| 3 Years: | 8% |
| 1 Year: | 1% |
| Return on Equity | |
|---|---|
| 10 Years: | 17% |
| 5 Years: | 19% |
| 3 Years: | 17% |
| Last Year: | 14% |
Last Updated: September 5, 2025, 2:51 pm
Balance Sheet
Last Updated: December 4, 2025, 2:35 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 6 | 6 |
| Reserves | 29 | 37 | 74 | 107 | 113 | 130 | 152 | 186 | 248 | 298 | 349 | 521 | 560 |
| Borrowings | 39 | 73 | 67 | 80 | 92 | 97 | 102 | 107 | 150 | 235 | 312 | 276 | 235 |
| Other Liabilities | 23 | 32 | 52 | 41 | 50 | 59 | 65 | 93 | 150 | 174 | 178 | 182 | 244 |
| Total Liabilities | 97 | 147 | 199 | 233 | 260 | 291 | 325 | 391 | 553 | 712 | 845 | 985 | 1,046 |
| Fixed Assets | 35 | 58 | 67 | 98 | 111 | 119 | 125 | 152 | 206 | 328 | 404 | 414 | 414 |
| CWIP | 2 | 4 | 2 | 2 | 2 | 4 | 9 | 10 | 21 | 14 | 10 | 12 | 26 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 60 | 85 | 131 | 132 | 146 | 168 | 191 | 229 | 326 | 371 | 430 | 560 | 605 |
| Total Assets | 97 | 147 | 199 | 233 | 260 | 291 | 325 | 391 | 553 | 712 | 845 | 985 | 1,046 |
Below is a detailed analysis of the balance sheet data for Carysil Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 6.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 6.00 Cr..
- For Reserves, as of Sep 2025, the value is 560.00 Cr.. The value appears strong and on an upward trend. It has increased from 521.00 Cr. (Mar 2025) to 560.00 Cr., marking an increase of 39.00 Cr..
- For Borrowings, as of Sep 2025, the value is 235.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 276.00 Cr. (Mar 2025) to 235.00 Cr., marking a decrease of 41.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 244.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 182.00 Cr. (Mar 2025) to 244.00 Cr., marking an increase of 62.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 1,046.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 985.00 Cr. (Mar 2025) to 1,046.00 Cr., marking an increase of 61.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 414.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 414.00 Cr..
- For CWIP, as of Sep 2025, the value is 26.00 Cr.. The value appears strong and on an upward trend. It has increased from 12.00 Cr. (Mar 2025) to 26.00 Cr., marking an increase of 14.00 Cr..
- For Investments, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Other Assets, as of Sep 2025, the value is 605.00 Cr.. The value appears strong and on an upward trend. It has increased from 560.00 Cr. (Mar 2025) to 605.00 Cr., marking an increase of 45.00 Cr..
- For Total Assets, as of Sep 2025, the value is 1,046.00 Cr.. The value appears strong and on an upward trend. It has increased from 985.00 Cr. (Mar 2025) to 1,046.00 Cr., marking an increase of 61.00 Cr..
Notably, the Reserves (560.00 Cr.) exceed the Borrowings (235.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -20.00 | -49.00 | -36.00 | -53.00 | -65.00 | -55.00 | -54.00 | -40.00 | -45.00 | -125.00 | -181.00 | -136.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 86 | 93 | 89 | 77 | 89 | 79 | 82 | 98 | 76 | 63 | 74 | 65 |
| Inventory Days | 206 | 239 | 184 | 216 | 213 | 170 | 180 | 161 | 212 | 184 | 285 | 290 |
| Days Payable | 131 | 120 | 174 | 138 | 167 | 99 | 87 | 124 | 162 | 111 | 143 | 105 |
| Cash Conversion Cycle | 160 | 212 | 99 | 155 | 135 | 150 | 175 | 136 | 126 | 137 | 216 | 251 |
| Working Capital Days | 15 | 6 | 14 | 18 | 11 | 22 | 34 | 41 | 40 | 19 | 25 | 49 |
| ROCE % | 23% | 22% | 20% | 14% | 12% | 16% | 16% | 22% | 27% | 18% | 17% | 15% |
Mutual Fund Holdings
| Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
|---|---|---|---|---|---|---|
| DSP Small Cap Fund | 1,000,000 | 0.6 | 101.29 | N/A | N/A | N/A |
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 |
| Basic EPS (Rs.) | 22.75 | 21.59 | 19.59 | 24.26 | 14.66 |
| Diluted EPS (Rs.) | 22.41 | 21.55 | 19.52 | 24.13 | 14.66 |
| Cash EPS (Rs.) | 35.29 | 33.86 | 29.58 | 31.08 | 19.47 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 185.39 | 132.01 | 114.69 | 96.25 | 72.66 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 185.39 | 132.01 | 114.69 | 96.25 | 72.66 |
| Revenue From Operations / Share (Rs.) | 287.17 | 254.98 | 221.83 | 181.27 | 116.02 |
| PBDIT / Share (Rs.) | 51.81 | 50.00 | 40.71 | 42.48 | 27.65 |
| PBIT / Share (Rs.) | 39.17 | 37.90 | 30.86 | 35.84 | 22.90 |
| PBT / Share (Rs.) | 30.93 | 30.12 | 25.44 | 32.25 | 20.17 |
| Net Profit / Share (Rs.) | 22.65 | 21.76 | 19.73 | 24.45 | 14.73 |
| NP After MI And SOA / Share (Rs.) | 22.44 | 21.59 | 19.58 | 24.26 | 14.66 |
| PBDIT Margin (%) | 18.04 | 19.60 | 18.34 | 23.43 | 23.82 |
| PBIT Margin (%) | 13.64 | 14.86 | 13.91 | 19.76 | 19.73 |
| PBT Margin (%) | 10.77 | 11.81 | 11.46 | 17.78 | 17.38 |
| Net Profit Margin (%) | 7.88 | 8.53 | 8.89 | 13.48 | 12.69 |
| NP After MI And SOA Margin (%) | 7.81 | 8.46 | 8.82 | 13.38 | 12.63 |
| Return on Networth / Equity (%) | 12.10 | 16.35 | 17.27 | 25.52 | 20.43 |
| Return on Capital Employeed (%) | 17.50 | 20.74 | 20.55 | 30.78 | 27.17 |
| Return On Assets (%) | 6.46 | 6.85 | 7.35 | 11.70 | 10.00 |
| Long Term Debt / Equity (X) | 0.16 | 0.32 | 0.25 | 0.15 | 0.11 |
| Total Debt / Equity (X) | 0.50 | 0.84 | 0.72 | 0.54 | 0.49 |
| Asset Turnover Ratio (%) | 0.89 | 0.87 | 0.93 | 0.91 | 0.76 |
| Current Ratio (X) | 1.51 | 1.17 | 1.16 | 1.27 | 1.33 |
| Quick Ratio (X) | 0.87 | 0.67 | 0.74 | 0.83 | 1.00 |
| Inventory Turnover Ratio (X) | 4.14 | 4.50 | 1.98 | 2.47 | 1.80 |
| Dividend Payout Ratio (NP) (%) | 8.91 | 9.26 | 6.12 | 9.89 | 13.64 |
| Dividend Payout Ratio (CP) (%) | 5.70 | 5.93 | 4.07 | 7.76 | 10.30 |
| Earning Retention Ratio (%) | 91.09 | 90.74 | 93.88 | 90.11 | 86.36 |
| Cash Earning Retention Ratio (%) | 94.30 | 94.07 | 95.93 | 92.24 | 89.70 |
| Interest Coverage Ratio (X) | 6.29 | 6.43 | 7.50 | 11.83 | 10.11 |
| Interest Coverage Ratio (Post Tax) (X) | 3.75 | 3.80 | 4.64 | 7.81 | 6.38 |
| Enterprise Value (Cr.) | 1976.83 | 2921.68 | 1669.06 | 2347.37 | 903.84 |
| EV / Net Operating Revenue (X) | 2.42 | 4.27 | 2.81 | 4.85 | 2.92 |
| EV / EBITDA (X) | 13.43 | 21.79 | 15.32 | 20.70 | 12.25 |
| MarketCap / Net Operating Revenue (X) | 2.18 | 3.85 | 2.45 | 4.58 | 2.67 |
| Retention Ratios (%) | 91.08 | 90.73 | 93.87 | 90.10 | 86.35 |
| Price / BV (X) | 3.37 | 7.43 | 4.80 | 8.74 | 4.32 |
| Price / Net Operating Revenue (X) | 2.18 | 3.85 | 2.45 | 4.58 | 2.67 |
| EarningsYield | 0.03 | 0.02 | 0.03 | 0.02 | 0.04 |
After reviewing the key financial ratios for Carysil Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 2.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 2.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 22.75. This value is within the healthy range. It has increased from 21.59 (Mar 24) to 22.75, marking an increase of 1.16.
- For Diluted EPS (Rs.), as of Mar 25, the value is 22.41. This value is within the healthy range. It has increased from 21.55 (Mar 24) to 22.41, marking an increase of 0.86.
- For Cash EPS (Rs.), as of Mar 25, the value is 35.29. This value is within the healthy range. It has increased from 33.86 (Mar 24) to 35.29, marking an increase of 1.43.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 185.39. It has increased from 132.01 (Mar 24) to 185.39, marking an increase of 53.38.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 185.39. It has increased from 132.01 (Mar 24) to 185.39, marking an increase of 53.38.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 287.17. It has increased from 254.98 (Mar 24) to 287.17, marking an increase of 32.19.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 51.81. This value is within the healthy range. It has increased from 50.00 (Mar 24) to 51.81, marking an increase of 1.81.
- For PBIT / Share (Rs.), as of Mar 25, the value is 39.17. This value is within the healthy range. It has increased from 37.90 (Mar 24) to 39.17, marking an increase of 1.27.
- For PBT / Share (Rs.), as of Mar 25, the value is 30.93. This value is within the healthy range. It has increased from 30.12 (Mar 24) to 30.93, marking an increase of 0.81.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 22.65. This value is within the healthy range. It has increased from 21.76 (Mar 24) to 22.65, marking an increase of 0.89.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 22.44. This value is within the healthy range. It has increased from 21.59 (Mar 24) to 22.44, marking an increase of 0.85.
- For PBDIT Margin (%), as of Mar 25, the value is 18.04. This value is within the healthy range. It has decreased from 19.60 (Mar 24) to 18.04, marking a decrease of 1.56.
- For PBIT Margin (%), as of Mar 25, the value is 13.64. This value is within the healthy range. It has decreased from 14.86 (Mar 24) to 13.64, marking a decrease of 1.22.
- For PBT Margin (%), as of Mar 25, the value is 10.77. This value is within the healthy range. It has decreased from 11.81 (Mar 24) to 10.77, marking a decrease of 1.04.
- For Net Profit Margin (%), as of Mar 25, the value is 7.88. This value is within the healthy range. It has decreased from 8.53 (Mar 24) to 7.88, marking a decrease of 0.65.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 7.81. This value is below the healthy minimum of 8. It has decreased from 8.46 (Mar 24) to 7.81, marking a decrease of 0.65.
- For Return on Networth / Equity (%), as of Mar 25, the value is 12.10. This value is below the healthy minimum of 15. It has decreased from 16.35 (Mar 24) to 12.10, marking a decrease of 4.25.
- For Return on Capital Employeed (%), as of Mar 25, the value is 17.50. This value is within the healthy range. It has decreased from 20.74 (Mar 24) to 17.50, marking a decrease of 3.24.
- For Return On Assets (%), as of Mar 25, the value is 6.46. This value is within the healthy range. It has decreased from 6.85 (Mar 24) to 6.46, marking a decrease of 0.39.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.16. This value is below the healthy minimum of 0.2. It has decreased from 0.32 (Mar 24) to 0.16, marking a decrease of 0.16.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.50. This value is within the healthy range. It has decreased from 0.84 (Mar 24) to 0.50, marking a decrease of 0.34.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.89. It has increased from 0.87 (Mar 24) to 0.89, marking an increase of 0.02.
- For Current Ratio (X), as of Mar 25, the value is 1.51. This value is within the healthy range. It has increased from 1.17 (Mar 24) to 1.51, marking an increase of 0.34.
- For Quick Ratio (X), as of Mar 25, the value is 0.87. This value is below the healthy minimum of 1. It has increased from 0.67 (Mar 24) to 0.87, marking an increase of 0.20.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 4.14. This value is within the healthy range. It has decreased from 4.50 (Mar 24) to 4.14, marking a decrease of 0.36.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 8.91. This value is below the healthy minimum of 20. It has decreased from 9.26 (Mar 24) to 8.91, marking a decrease of 0.35.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 5.70. This value is below the healthy minimum of 20. It has decreased from 5.93 (Mar 24) to 5.70, marking a decrease of 0.23.
- For Earning Retention Ratio (%), as of Mar 25, the value is 91.09. This value exceeds the healthy maximum of 70. It has increased from 90.74 (Mar 24) to 91.09, marking an increase of 0.35.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 94.30. This value exceeds the healthy maximum of 70. It has increased from 94.07 (Mar 24) to 94.30, marking an increase of 0.23.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 6.29. This value is within the healthy range. It has decreased from 6.43 (Mar 24) to 6.29, marking a decrease of 0.14.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 3.75. This value is within the healthy range. It has decreased from 3.80 (Mar 24) to 3.75, marking a decrease of 0.05.
- For Enterprise Value (Cr.), as of Mar 25, the value is 1,976.83. It has decreased from 2,921.68 (Mar 24) to 1,976.83, marking a decrease of 944.85.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 2.42. This value is within the healthy range. It has decreased from 4.27 (Mar 24) to 2.42, marking a decrease of 1.85.
- For EV / EBITDA (X), as of Mar 25, the value is 13.43. This value is within the healthy range. It has decreased from 21.79 (Mar 24) to 13.43, marking a decrease of 8.36.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 2.18. This value is within the healthy range. It has decreased from 3.85 (Mar 24) to 2.18, marking a decrease of 1.67.
- For Retention Ratios (%), as of Mar 25, the value is 91.08. This value exceeds the healthy maximum of 70. It has increased from 90.73 (Mar 24) to 91.08, marking an increase of 0.35.
- For Price / BV (X), as of Mar 25, the value is 3.37. This value exceeds the healthy maximum of 3. It has decreased from 7.43 (Mar 24) to 3.37, marking a decrease of 4.06.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 2.18. This value is within the healthy range. It has decreased from 3.85 (Mar 24) to 2.18, marking a decrease of 1.67.
- For EarningsYield, as of Mar 25, the value is 0.03. This value is below the healthy minimum of 5. It has increased from 0.02 (Mar 24) to 0.03, marking an increase of 0.01.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Carysil Ltd:
- Net Profit Margin: 7.88%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 17.5% (Industry Average ROCE: 12.44%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 12.1% (Industry Average ROE: 14.63%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 3.75
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 0.87
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 27.3 (Industry average Stock P/E: 39.51)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.5
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 7.88%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Ceramics/Tiles/Sanitaryware | A-702, 7th Floor, Kanakia Wall Street, Mumbai Maharashtra 400093 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Chirag Parekh | Chairman & Managing Director |
| Mr. Anand Sharma | Executive Director & Group CFO |
| Dr. Sonal V Ambani | Independent Director |
| Mr. Rustam N Mulla | Independent Director |
| Mrs. Katja Larsen | Independent Director |
| Mr. Prabhakar R Dalal | Independent Director |
| Mr. Pradyumna R Vyas | Independent Director |
| Dr. Savan Godiawala | Independent Director |
FAQ
What is the intrinsic value of Carysil Ltd?
Carysil Ltd's intrinsic value (as of 14 January 2026) is ₹632.08 which is 18.86% lower the current market price of ₹779.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's ₹2,215 Cr. market cap, FY2025-2026 high/low of ₹1,072/482, reserves of ₹560 Cr, and liabilities of ₹1,046 Cr.
What is the Market Cap of Carysil Ltd?
The Market Cap of Carysil Ltd is 2,215 Cr..
What is the current Stock Price of Carysil Ltd as on 14 January 2026?
The current stock price of Carysil Ltd as on 14 January 2026 is ₹779.
What is the High / Low of Carysil Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Carysil Ltd stocks is ₹1,072/482.
What is the Stock P/E of Carysil Ltd?
The Stock P/E of Carysil Ltd is 27.3.
What is the Book Value of Carysil Ltd?
The Book Value of Carysil Ltd is 199.
What is the Dividend Yield of Carysil Ltd?
The Dividend Yield of Carysil Ltd is 0.30 %.
What is the ROCE of Carysil Ltd?
The ROCE of Carysil Ltd is 15.4 %.
What is the ROE of Carysil Ltd?
The ROE of Carysil Ltd is 14.5 %.
What is the Face Value of Carysil Ltd?
The Face Value of Carysil Ltd is 2.00.